| Date Filed | Type | Description |
| 06/16/2023 |
4
| Gilbert Halley E (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.57, valued at
$39.3k
|
|
| 06/15/2023 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 06/02/2023 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,375 shares
@ $0
Granted 12,220 options to buy
@ $7.51, valued at
$91.8k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 4,312 shares
@ $0
Granted 11,796 options to buy
@ $20.29, valued at
$239.3k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/30/2021 |
4
| Gilbert Halley E (Chief Legal Officer) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 45,858 shares
@ $0 |
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 13,391 options to buy
@ $27.77, valued at
$371.9k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Gilbert Halley E (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $8.35, valued at
$167k
|
|
| 06/11/2020 |
3
| Gilbert Halley E (Director) has filed a Form 3 on Vaxcyte, Inc. |
| 05/01/2020 |
4
| Gilbert Halley E (Director) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 37,500 options to buy
@ $26, valued at
$975k
|
|
| 05/01/2020 |
3
| Gilbert Halley E (Director) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
| 04/29/2020 |
4
| Gilbert Halley E (Director) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $9.25, valued at
$370k
|
|
| 04/29/2020 |
3
| Gilbert Halley E (Director) has filed a Form 3 on CytomX Therapeutics, Inc. |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2019 |
4
| Gilbert Halley E (Chief Admin Officer & SVP) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 41,150 shares
@ $0 |
|
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2019 |
4
| Gilbert Halley E (Chief Admin Officer & SVP) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 4,055 shares
@ $10.53, valued at
$42.7k
|
|
| 04/03/2019 |
4
| Gilbert Halley E (Chief Admin Officer & SVP) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 17,165 shares
@ $0
Granted 1,506 options to buy
@ $0
Granted 4,326 options to buy
@ $0
Granted 5,949 options to buy
@ $0
Granted 16,804 options to buy
@ $0
Granted 2,472 options to buy
@ $0 |
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Gilbert Halley E (Chief Legal Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Disposed of 20,449 options to buy
@ $4.89, valued at
$100k
Acquired 20,449 options to buy
@ $4.89, valued at
$100k
Disposed of 20,000 options to buy
@ $5.48, valued at
$109.6k
Acquired 20,000 options to buy
@ $5.48, valued at
$109.6k
|
|
| 08/02/2018 |
4
| Gilbert Halley E (Chief Legal Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 07/05/2018 |
4
| Gilbert Halley E (Chief Legal Officer) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Sold 29,551 shares
@ $19.75, valued at
$583.6k
Exercised 29,551 options to buy
@ $4.89, valued at
$144.5k
|
|
|